Jibing Chen, Doctor

Activated CIK and CD3-MUC1 Bispecific Antibody in Treating Liver Cancer

Activated CIK and CD3-MUC1 Bispecific Antibody in Treating Breast Cancer

Activated CIK and CD3-MUC1 Bispecific Antibody in Treating colorectal cancer

Activated CIK and CD3-MUC1 Bispecific Antibody in Treating Gastric cancer

Activated CIK and CD3-MUC1 Bispecific Antibody in Treating Kidney Cancer

Activated CIK and CD3-MUC1 Bispecific Antibody in Treating Lung cancer

Activated CIK and CD3-MUC1 Bispecific Antibody in Treating Pancreatic Cancer

Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Breast Cancer

8 unique interventions2 categories

Analytics

Trial Phases

Phase 27

Trial Status

Other7

Role Distribution

Other Roles7

Activity Timeline

Clinical Trials (7)

NCT03524261Phase 2Withdrawn

Advanced Breast Cancer

StudychairStart date: 2019-05-20

NCT03509298Phase 2Withdrawn

Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Pancreatic Cancer

Advanced Pancreatic Cancer

StudychairStart date: 2018-04-12

NCT03540199Phase 2Withdrawn

Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Kidney Cancer

Advanced Kidney Cancer

StudychairStart date: 2018-04-10

NCT03524274Phase 2Withdrawn

Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Colorectal Cancer

Advanced Colorectal Cancer

StudychairStart date: 2018-04-05

NCT03554395Phase 2Withdrawn

Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Gastric Cancer

Advanced Gastric Cancer

StudychairStart date: 2018-04-05

NCT03501056Phase 2Withdrawn

Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Lung Cancer

Advanced Lung Cancer

StudychairStart date: 2018-03-27

NCT03484962Phase 2Withdrawn

Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Liver Cancer

Advanced Liver Cancer

StudychairStart date: 2018-03-25

Research Network

Collaboration Network

1 collaborators·0 connections

Network Legend

KOL

Current Investigator

High-influence Collaborator

Collaborator

Click: view details

Double-click: go to profile

Drag: move node

Research Areas & Affiliations

Therapeutic Areas

Advanced Breast Cancer1 Advanced Colorectal Cancer1 Advanced Gastric Cancer1 Advanced Kidney Cancer1 Advanced Liver Cancer1 Advanced Lung Cancer1 Advanced Pancreatic Cancer1

Affiliations

Guangzhou Fuda Cancer Hospital

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Seock-Ah Im, MD, PhD

Seoul National University Hospital

5 trials

Shared therapeutic areas:

Advanced Breast CancerAdvanced Gastric Cancer

Similarity Score9%

Herui Yao, PhD

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

11 trials

Shared therapeutic areas:

Advanced Pancreatic Cancer

Carmen Guillén, MD

Hospital Universitario Ramon y Cajal

2 trials

Shared therapeutic areas:

Do-Youn Oh, MD, PhD

Seoul National University Hospital

7 trials

Shared therapeutic areas:

Advanced Gastric Cancer

Tracy E Crane, Phd, RDN

University of Miami

5 trials

Shared therapeutic areas:

Yung-Jue Bang, MD, PhD

Seoul National University Hospital

4 trials

Shared therapeutic areas:

Advanced Gastric Cancer

Fei Ma

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

6 trials

Shared therapeutic areas:

Advanced Pancreatic Cancer

David Cunningham

Royal Marsden NHS Foundation Trust

13 trials

Shared therapeutic areas:

Jian Zhang, PhD

Fudan University

5 trials

Shared therapeutic areas:

Advanced Colorectal Cancer

Aimin Zang

Affiliated Hospital of Hebei University

2 trials

Shared therapeutic areas: